Karen H. Thedinga

CGP 37849 and CGP 39551: novel and potent competitive N‐methyl‐<scp>d</scp>‐aspartate receptor antagonists with oral activity

Graham E. Fagg, H.‐R. Olpe, M.F. Pozza et al. · British Journal of Pharmacology · 1990 · 188 citations · Full text

Molecular Pharmacology, Cgp 37849, Biochemistry +15

Inhibition of nucleoside transport by a new series of compounds related to lidoflazine and mioflazine

Adriaan P. IJzerman, Karen H. Thedinga, Arsène F.C.M. Custers et al. · European Journal of Pharmacology Molecular Pharmacology · 1989 · 37 citations

Nucleoside Transport, Biochemistry, Natural Sciences +9

A comparative analysis of the neuroprotective properties of competitive and uncompetitive n-methyl-d-aspartate receptor antagonists in vivo: Implications for the process of excitotoxic degeneration and its therapy

Lourdes Massieu, Karen H. Thedinga, Mary McVey et al. · Neuroscience · 1993 · 35 citations

Neurodegenerative Diseases, Medicine, Pharmacology +12

The (NMDA) receptor complex: A stoichiometric analysis of radioligand binding domains

Karen H. Thedinga, Michel S. Benedict, Graham E. Fagg · Neuroscience Letters · 1989 · 26 citations

Stoichiometric Analysis, Biochemistry, G Protein-coupled Receptor +9

Evaluation of quinolinic acid induced excitotoxic neurodegeneration in rat striatum by quantitative magnetic resonance imaging in vivo

Dirk Sauer, Peter R. Allegrini, Karen H. Thedinga et al. · Journal of Neuroscience Methods · 1992 · 24 citations

Excitotoxic Neurodegeneration, Neurodegenerative Diseases, Neurophysiology +12